prednisolone has been researched along with Langerhans Cell Sarcoma in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Langerhans Cell Sarcoma: Rare malignant neoplasm of dendritic LANGERHANS CELLS exhibiting atypical cytology, frequent mitoses, and aggressive clinical behavior. They can be distinguished from other histiocytic and dendritic proliferations by immunohistochemical and ultrastructure studies. Cytologically benign proliferations of Langerhans cells are called LANGERHANS CELL HISTIOCYTOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuseya, H | 1 |
| Nakao, T | 1 |
| Tsutsumi, M | 1 |
| Nakaya, Y | 1 |
| Horiuchi, M | 1 |
| Yoshida, M | 1 |
| Yoshimura, T | 1 |
| Hayashi, Y | 1 |
| Fukushima, H | 1 |
| Inoue, T | 1 |
| Aiba, T | 1 |
| Yamane, T | 1 |
1 other study available for prednisolone and Langerhans Cell Sarcoma
| Article | Year |
|---|---|
[Durable remission of Langerhans cell sarcoma attained by autologous hematopoietic stem cell transplantation following surgical resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Ce | 2019 |